105 related articles for article (PubMed ID: 6087115)
1. Theoretical structure-activity studies of benzodiazepine analogues. Requirements for receptor affinity and activity.
Loew GH; Nienow JR; Poulsen M
Mol Pharmacol; 1984 Jul; 26(1):19-34. PubMed ID: 6087115
[TBL] [Abstract][Full Text] [Related]
2. Quinazolines and 1,4-benzodiazepines. 92. Conformational recognition of the receptor by 1,4-benzodiazepines.
Blount JF; Fryer RI; Gilman NW; Todaro LJ
Mol Pharmacol; 1983 Nov; 24(3):425-8. PubMed ID: 6314115
[TBL] [Abstract][Full Text] [Related]
3. Theoretical structure-activity studies of beta-carboline analogs. Requirements for benzodiazepine receptor affinity and antagonist activity.
Loew GH; Nienow J; Lawson JA; Toll L; Uyeno ET
Mol Pharmacol; 1985 Jul; 28(1):17-31. PubMed ID: 2862573
[TBL] [Abstract][Full Text] [Related]
4. Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC.
Ghose AK; Crippen GM
Mol Pharmacol; 1990 May; 37(5):725-34. PubMed ID: 2160062
[TBL] [Abstract][Full Text] [Related]
5. The nature of 1,4-benzodiazepines/receptor interactions.
Borea PA; Gilli G
Arzneimittelforschung; 1984; 34(6):649-52. PubMed ID: 6091702
[TBL] [Abstract][Full Text] [Related]
6. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
Frølund B; Jensen LS; Guandalini L; Canillo C; Vestergaard HT; Kristiansen U; Nielsen B; Stensbøl TB; Madsen C; Krogsgaard-Larsen P; Liljefors T
J Med Chem; 2005 Jan; 48(2):427-39. PubMed ID: 15658856
[TBL] [Abstract][Full Text] [Related]
7. Quantitative structure-activity relationship studies on benzodiazepine receptor binding: investigation of interaction model.
Gupta SP; Mulchandani V
Indian J Biochem Biophys; 1993 Jun; 30(3):181-6. PubMed ID: 8406550
[TBL] [Abstract][Full Text] [Related]
8. Stereochemical features controlling binding and intrinsic activity properties of benzodiazepine-receptor ligands.
Borea PA; Gilli G; Bertolasi V; Ferretti V
Mol Pharmacol; 1987 Apr; 31(4):334-44. PubMed ID: 3033465
[TBL] [Abstract][Full Text] [Related]
9. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M
Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545
[TBL] [Abstract][Full Text] [Related]
10. Molecular determinants of mu receptor recognition for the fentanyl class of compounds.
Cometta-Morini C; Maguire PA; Loew GH
Mol Pharmacol; 1992 Jan; 41(1):185-96. PubMed ID: 1310142
[TBL] [Abstract][Full Text] [Related]
11. Conformational preferences in a benzodiazepine series of potent nonpeptide fibrinogen receptor antagonists.
Keenan RM; Callahan JF; Samanen JM; Bondinell WE; Calvo RR; Chen L; DeBrosse C; Eggleston DS; Haltiwanger RC; Hwang SM; Jakas DR; Ku TW; Miller WH; Newlander KA; Nichols A; Parker MF; Southhall LS; Uzinskas I; Vasko-Moser JA; Venslavsky JW; Wong AS; Huffman WF
J Med Chem; 1999 Feb; 42(4):545-59. PubMed ID: 10052962
[TBL] [Abstract][Full Text] [Related]
12. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
[TBL] [Abstract][Full Text] [Related]
13. Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs.
Baur R; Tan KR; Lüscher BP; Gonthier A; Goeldner M; Sigel E
J Neurochem; 2008 Sep; 106(6):2353-63. PubMed ID: 18643789
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP
J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
[TBL] [Abstract][Full Text] [Related]
16. Axial chirality and affinity at the GABA(A) receptor of pyrimido[1,2-a][1,4]benzodiazepines and related compounds.
Lee S; Kamide T; Tabata H; Takahashi H; Shiro M; Natsugari H
Bioorg Med Chem; 2008 Nov; 16(21):9519-23. PubMed ID: 18829330
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists.
Thomas JB; Mascarella SW; Rothman RB; Partilla JS; Xu H; McCullough KB; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
J Med Chem; 1998 May; 41(11):1980-90. PubMed ID: 9599247
[TBL] [Abstract][Full Text] [Related]
18. Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.
Bang-Andersen B; Lenz SM; Skjaerbaek N; Søby KK; Hansen HO; Ebert B; Bøgesø KP; Krogsgaard-Larsen P
J Med Chem; 1997 Aug; 40(18):2831-42. PubMed ID: 9288165
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine receptors: differential ligand interactions and purification of the receptor protein.
Möhler H
Adv Biochem Psychopharmacol; 1983; 38():47-56. PubMed ID: 6142607
[TBL] [Abstract][Full Text] [Related]
20. Rigid phencyclidine analogues. Binding to the phencyclidine and sigma 1 receptors.
Moriarty RM; Enache LA; Zhao L; Gilardi R; Mattson MV; Prakash O
J Med Chem; 1998 Feb; 41(4):468-77. PubMed ID: 9484497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
